Jul 22, 2025
1:12
For every 12 shares held, investors received 1. The price per share adjusted from $0.75 to $8.94.
The split itself did not change the total investment value.
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) operates in the Pharmaceuticals: major industry.
CNS Pharmaceuticals, Inc. company overviewCNS Pharmaceuticals, Inc.'s most recent stock split was on July 22, 2025. It was a 1-for-12 reverse split, so shareholders received 1 share for every 12 they held.
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) has split its stock 4 times: a 1-for-30 reverse split on November 29, 2022, a 1-for-50 reverse split on June 5, 2024, a 1-for-50 reverse split on February 21, 2025, and a 1-for-12 reverse split on July 22, 2025.
CNS Pharmaceuticals, Inc. has split its stock 4 times. This history records 4 reverse splits between November 29, 2022 and July 22, 2025.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In CNS Pharmaceuticals, Inc.'s 1-for-12 reverse split on July 22, 2025, every 12 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
CNS Pharmaceuticals, Inc. has not announced a new split in our records. Its most recent split was on July 22, 2025, 1 year ago. Companies announce splits in advance, and any new NASDAQ:CNSP split will appear on this page.